Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
about
A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core DomainComputational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integraseNovel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.
P2860
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@ast
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@en
type
label
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@ast
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@en
prefLabel
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@ast
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
@en
P2860
P356
P1476
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
@en
P2093
Krishan K Pandey
P2860
P356
10.2147/HIV.S39178
P407
P577
2014-05-16T00:00:00Z